Medical Journals

Quantitative Phosphoproteomics of Vasopressin-sensitive Renal Cells: Regulation of Aquaporin-2 Phosphorylation at Two Sites.

Authors:
  • Hoffert Jason D
  • Pisitkun Trairak
  • Wang Guanghui
  • Shen Rong-Fong
  • Knepper Mark A

From: National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: May 2006
  • ISSN: 0027-8424
  • Volume: 103
  • Issue: 18
  • Pages: 7159-64
  • Medium: Print
  • Language: English
  • Citation (JAMA): Hoffert Jason D, Pisitkun Trairak, Wang Guanghui, et al. Quantitative Phosphoproteomics of Vasopressin-sensitive Renal Cells: Regulation of Aquaporin-2 Phosphorylation at Two Sites.. Proc. Natl. Acad. Sci. U.S.A. May 2006;103:7159-64

Abstract

Protein phosphorylation plays a key role in vasopressin signaling in the renal-collecting duct. Large-scale identification and quantification of phosphorylation events triggered by vasopressin is desirable to gain a comprehensive systems-level understanding of this process. We carried out phosphoproteomic analysis of rat inner medullary collecting duct cells by using a combination of phosphopeptide enrichment by immobilized metal affinity chromatography and phosphorylation site identification by liquid chromatography-mass spectrometry(n) neutral loss scanning. A total of 714 phosphorylation sites on 223 unique phosphoproteins were identified from inner medullary collecting duct samples treated short-term with either calyculin A or vasopressin. A number of proteins involved in cytoskeletal reorganization, vesicle trafficking, and transcriptional regulation were identified. Previously unidentified phosphorylation sites were found for membrane proteins essential to collecting duct physiology, including eight sites among aquaporin-2 (AQP2), aquaporin-4, and urea transporter isoforms A1 and A3. Through label-free quantification of phosphopeptides, we identified a number of proteins that significantly changed phosphorylation state in response to short-term vasopressin treatment: AQP2, Bclaf1, LRRC47, Rgl3, and SAFB2. In the presence of vasopressin, AQP2 monophosphorylated at S256 and diphosphorylated AQP2 (pS256/261) increased in abundance, whereas AQP2 monophosphorylated at S261 decreased, raising the possibility that both sites are involved in vasopressin-dependent AQP2 trafficking. This study reveals the practicality of liquid chromatography-mass spectrometry(n) neutral loss scanning for large-scale identification and quantification of protein phosphorylation in the analysis of cell signaling in a native mammalian system.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Aquaporin 2, Chromatography, Liquid, Kidney Tubules, Collecting, Mass Spectrometry, Molecular Sequence Data, Phosphopeptides, Phosphorylation, Proteome, Rats, Reproducibility of Results, Signal Transduction, Vasopressins


Check for Full Text / PubMed Unique Identifier (PMID): 16641100


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.